Overview
Lobbying Costs
1,000,000€ - 1,249,999€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
5.15 Fte (15)
Lobbyists with EP accreditation
3
High-level Commission meetings
12
Lobbying Costs over the years
-
Info
GlaxoSmithKline (GSK)
EU Transparency Register
7990322925-77 First registered on 06 Jan 2009
Goals / Remit
We are a science-led global healthcare company with a special purpose to improve the quality of human life. Our goal is to unite science, talent and technology to get ahead of disease together. We help improve the health of millions of people around the world by discovering, developing and manufacturing innovative medicines, vaccines and consumer healthcare products. Our operations span the value chain from identifying, researching, developing and testing ground-breaking discoveries, to regulatory approval, manufacturing and commercialisation. We are on our way to become two great, new companies – new GSK and new Consumer Healthcare (named Haleon). Our scale and strong EU footprint give us the opportunity to make a positive impact on the lives of people across the EU.
Main EU files targeted
We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses. This includes topics such as R&D and clinical trials, the EU Beating Cancer Plan, pandemic preparedness/European Health Union, health technology assessment, antimicrobial resistance, digital health, pharmaceutical legislation, medical devices, vaccines, trade, industrial strategy, IP, environment.
Address
Head Office
Great West Road, 980
Brentford, Middlesex TW8 9GS
UNITED KINGDOMEU Office
37 Square de Meeûs
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
15
Employment time Lobbyists 100% 1 75% 1 50% 3 25% 6 10% 4 Lobbyists (Full time equivalent)
5.15
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 13 May 2022
Name Start date End Date Bonifac Abel MAKKAI 20 Mar 2024 02 Oct 2024 Sofia BENITO KWIECINSKI 20 Feb 2024 19 Feb 2025 Alberto GIUMMARRA 12 Mar 2024 11 Mar 2025 Gisela PAYERAS BAILLY 20 Mar 2024 02 Oct 2024 Mr Bonifac Abel MAKKAI 20 Mar 2024 15 Apr 2024 Ms Gisela Payeras Bailly 20 Mar 2024 15 Apr 2024 Mr Alberto Giummarra 12 Mar 2024 15 Apr 2024 Ms Sofia BENITO KWIECINSKI 20 Feb 2024 15 Apr 2024 Mr Alberto Giummarra 18 Mar 2023 12 Mar 2024 Ms Renatte Georgescu 17 Mar 2023 16 Mar 2024 Ms Sofia BENITO KWIECINSKI 22 Feb 2023 20 Feb 2024 Ms Chloe CROSS 02 Aug 2022 02 Aug 2023 Ms Gisela Payeras Bailly 09 Apr 2022 08 Apr 2023 Mr Alberto Giummarra 01 Apr 2022 18 Mar 2023 Ms Renatte Georgescu 01 Apr 2022 17 Mar 2023 Ms Chloe CROSS 15 Apr 2021 15 Apr 2022 Ms Gisela Payeras Bailly 15 Apr 2021 09 Apr 2022 Mr Alberto Giummarra 07 Apr 2021 01 Apr 2022 Ms Renatte Georgescu 07 Apr 2021 01 Apr 2022 Mihaela ALIONTE 22 Feb 2020 20 Feb 2021 Mr Alberto Giummarra 22 Feb 2020 20 Feb 2021 Ms Renatte Georgescu 08 Feb 2020 06 Feb 2021 Ms Katja Murray 25 Jan 2020 01 Feb 2021 Ms Valentina Laurenzia Ancona 25 Jan 2020 01 Feb 2021 Ms Gisela Payeras Bailly 08 Nov 2019 07 Nov 2020 Ms Georgia Catherine JANE CASSARINO 17 Oct 2019 17 Oct 2020 Mr Guilherme Monteiro Ferreira Borges Dos Santos 05 Sep 2019 05 Sep 2020 Mr Christian Baracat 05 Sep 2019 18 Oct 2019 Mr Paulus Lambertus Antonius van Hoof 17 Aug 2019 15 Aug 2020 Ms Renatte Georgescu 02 Feb 2019 08 Feb 2020 Ms Gisela Payeras Bailly 31 Oct 2018 31 Oct 2019 Ms Georgia Catherine JANE CASSARINO 26 Oct 2018 17 Oct 2019 Mr Christian Baracat 05 Sep 2018 05 Sep 2019 Mr Paulus Lambertus Antonius van Hoof 07 Aug 2018 07 Aug 2019 Mr Guilherme Monteiro Ferreira Borges Dos Santos 19 Jun 2018 19 Jun 2019 Ms Gisela Payeras Bailly 27 Oct 2017 26 Oct 2018 Ms Georgia Catherine JANE CASSARINO 27 Oct 2017 25 Oct 2018 Mr Christian Baracat 31 Aug 2017 17 Aug 2018 Mr Paulus Lambertus Antonius van Hoof 31 Aug 2017 07 Aug 2018 Mr Guilherme Monteiro Ferreira Borges Dos Santos 10 Oct 2016 07 Oct 2017 Ms Gisela Payeras Bailly 05 Sep 2016 31 Aug 2017 Mr Christian Baracat 22 Aug 2016 02 Aug 2017 Mr Paulus Lambertus Antonius van Hoof 22 Aug 2016 02 Aug 2017 Mr Guilherme Monteiro Ferreira Borges Dos Santos 26 Sep 2015 25 Sep 2016 Ms Karin Jeanette Drielsma 22 Sep 2015 31 Jan 2016 Mr Christian Baracat 29 Aug 2015 23 Aug 2016 Ms Gisela Payeras Bailly 29 Aug 2015 28 Aug 2016 Mr Paulus Lambertus Antonius van Hoof 31 Jul 2015 29 Jul 2016 Ms Karin Jeanette Drielsma 06 Aug 2014 04 Aug 2015 Ms Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 28 Aug 2015 Ms Gisela Payeras Bailly 26 Aug 2014 19 Aug 2015 Mr Nicholas Collinge Crosby 08 Oct 2014 03 Jun 2015 Ms Diana Mereu 04 Oct 2014 03 Jun 2015 Mr Guilherme Monteiro Ferreira Borges Dos Santos 30 Sep 2014 26 Sep 2015 Mrs Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 27 Jan 2015 Mr Christian Baracat 26 Aug 2014 19 Aug 2015 Mrs Gisela Payeras Bailly 26 Aug 2014 27 Jan 2015 Mrs Karin Jeanette Drielsma 06 Aug 2014 27 Jan 2015 Mr Paulus Lambertus Antonius van Hoof 02 Aug 2014 31 Jul 2015 Mr Guilherme Monteiro Ferreira Borges Dos Santos 28 Sep 2013 27 Sep 2014 Mrs Elisaveta Voynova 28 Sep 2013 27 Sep 2014 Mr Paulus Lambertus Antonius van Hoof 25 Jul 2013 24 Jul 2014 Mrs Gisela Payeras Bailly 25 Jul 2013 24 Jul 2014 Mr Christopher Black 23 Jul 2013 20 Jul 2014 Mr Johan Christoffer Thor 23 Jul 2013 20 Jul 2014 Mrs Karin Jeanette Drielsma 23 Jul 2013 20 Jul 2014 Mrs Sophie Renee Jeanne Marie Philippine Crousse 23 Jul 2013 20 Jul 2014 Mr Philippe GHYSSELS 17 Jan 2012 08 Feb 2013 Complementary Information
Our Brussels office has five representatives, three of which focus on EU affairs and two whose work focuses on trade associations and initiatives within the EU Member States. The remaining colleagues are involved in very limited EU activities and spend less than 25% of their time on in-scope activities; as per the new guidance under the Inter-Institutional Agreement of 2021 we have included these individuals. GSK also follows the guidelines provided by EFPIA regarding this registration.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Association of the European Self-Medication Industry (AESGP)
European Brands Association (AIM)
American Chamber of Commerce to the European Union (AmChamEU)
Cosmetics Europe
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Vaccines Europe (VE)
EPC
Friends of Europe
Ambrosetti
Hanbury Strategy
International Pharmaceutical Aerosol Consortium (IPAC)
Digital Europe
MedTech Europe
European Roundtable for Industry (ERT)Member organisations
N/A
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
1,000,000€ - 1,249,999€
Major contributions in closed year
Type Name Amount Grant Horizon 2020 260,088€ Intermediaries for closed year
Name Amount hanbury strategy and communications ltd 100,000€ - 199,999€ vintura 50,000€ - 99,999€ Intermediaries for current year
Name hanbury strategy and communications ltd vintura Closed year Costs
1,000,000€ - 1,249,999€
Other financial info
For the declaration of funding received from EU institutions, GSK is following the Transparency Register Implementing Guidelines from September 2021, with the declared amount corresponding to the information provided by the European Financial Transparency System. Currently, this information is referring to the closed financial year of 2020, and will be updated to 2021 when the update of the European Financial Transparency System is made, therefore it is not yet possible to confirm the total amount of grants for the previous or current financial year.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Mainly via participation in events organised by trade associations and think tanks. In May 2021, we held a virtual event on women’s cancers in collaboration with two patient organisations, bringing together key stakeholders to discuss how Europe’s Beating Cancer Plan could positively impact people affected by women’s cancers in the EU. In December 2021, we sponsored the European Health Summit, with GSK participating in a panel on the EU Health Emergency Preparedness and Response Authority (HERA).
Other activities
None
- Meetings
Meetings
12 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 28 Apr 2021 Location Brussels Subject EU vaccine production and pandemic preparedness Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 11 Feb 2021 Location webex Subject vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 31 May 2018 Location Brussels Subject Brexit preparedness Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 23 Mar 2018 Location Brussels Subject IP regime generic manufacturers in the pharmaceutical industry Cabinet Cabinet of Commissioner Pierre Moscovici Portfolio Economic and Financial Affairs, Taxation and Customs Attending - Leila Fernandez-Stembridge (Cabinet member)
-
Date 01 Dec 2017 Location Brussels Subject FTA implementation & transparency / trade relations with China, Turkey, Russia / importance of including vaccines in trade negotiations Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Maria Asenius (Cabinet member)
- Nele Eichhorn (Cabinet member)
-
Date 09 Nov 2017 Location Brussels Subject Innovation in the pharmaceutical sector, SPC, health technology assessments Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Marika Lautso-Mousnier (Cabinet member)
-
Date 26 Jun 2017 Location Brussels Subject Antimicrobial resistance (AMR) Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
-
Date 30 Sep 2015 Location Brussels Subject Vaccination Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Paula Duarte Gaspar (Cabinet member)
-
Date 24 Sep 2015 Location Brussels Subject Challenges of the pharma industry Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
-
Date 18 May 2015 Location Brussels Subject Access to medicines in Africa Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)
-
Date 16 Jan 2015 Location PRAGUE, CZECH REPUBLIC Subject Round Table on Gender Diversity Cabinet Cabinet of Commissioner Věra Jourová Portfolio Justice, Consumers and Gender Equality Attending - Věra Jourová (Commissioner)
Other Lobbyists -
Date 05 Dec 2014 Location Brussels Subject Life sciences contribution to growth and jobs Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Aura Salla (Cabinet member)
- Heidi Jern (Cabinet member)
- Meetings